Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
Authors
Keywords
Parkinson’s disease, Alpha synuclein, Cerebrospinal fluid biomarkers, Amyloid oligomers, Biomarkers
Journal
Molecular Neurodegeneration
Volume 11, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-01-19
DOI
10.1186/s13024-016-0072-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interference from Heterophilic Antibodies in Amyloid-β Oligomer ELISAs
- (2017) Dag Sehlin et al. JOURNAL OF ALZHEIMERS DISEASE
- Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils
- (2015) Mustafa T. Ardah et al. NEUROBIOLOGY OF DISEASE
- Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology
- (2015) Nishant N. Vaikath et al. NEUROBIOLOGY OF DISEASE
- Increased CSF α-synuclein levels in Alzheimer's disease: Correlation with tau levels
- (2014) Sylvie Slaets et al. Alzheimers & Dementia
- Cerebrospinal Fluid α-Synuclein Predicts Cognitive Decline in Parkinson Disease Progression in the DATATOP Cohort
- (2014) Tessandra Stewart et al. AMERICAN JOURNAL OF PATHOLOGY
- Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo
- (2014) Edward Rockenstein et al. BRAIN
- Correlates of cerebrospinal fluid levels of oligomeric- and total-α-synuclein in premotor, motor and dementia stages of Parkinson’s disease
- (2014) Yaroslau Compta et al. JOURNAL OF NEUROLOGY
- Alpha-synuclein and tau: teammates in neurodegeneration?
- (2014) Simon Moussaud et al. Molecular Neurodegeneration
- Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease
- (2014) Lucilla Parnetti et al. MOVEMENT DISORDERS
- Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease
- (2014) Anke A. Dijkstra et al. MOVEMENT DISORDERS
- CSF biomarkers and clinical progression of Parkinson disease
- (2014) S. Hall et al. NEUROLOGY
- Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
- (2014) Oskar Hansson et al. Alzheimers Research & Therapy
- Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicity
- (2014) Mustafa T. Ardah et al. Frontiers in Aging Neuroscience
- Elevated levels of cerebrospinal fluid α-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriers
- (2014) Jan O. Aasly et al. Frontiers in Aging Neuroscience
- Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
- (2014) Lucilla Parnetti et al. Frontiers in Aging Neuroscience
- Reduced α-synuclein levels in cerebrospinal fluid in Parkinson's disease are unrelated to clinical and imaging measures of disease severity
- (2013) K. D. van Dijk et al. EUROPEAN JOURNAL OF NEUROLOGY
- Elevated Levels of α-Synuclein Oligomer in the Cerebrospinal Fluid of Drug-Naïve Patients with Parkinson's Disease
- (2012) Min Jeong Park et al. Journal of Clinical Neurology
- Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease
- (2012) J. M. Milber et al. NEUROLOGY
- Baicalein Inhibits Formation of α-Synuclein Oligomers within Living Cells and Prevents Aβ Peptide Fibrillation and Oligomerisation
- (2011) Jia-Hong Lu et al. CHEMBIOCHEM
- α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
- (2011) Brit Mollenhauer et al. LANCET NEUROLOGY
- Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias
- (2011) Lucilla Parnetti et al. MOVEMENT DISORDERS
- Detection of elevated levels of -synuclein oligomers in CSF from patients with Parkinson disease
- (2010) T. Tokuda et al. NEUROLOGY
- Detection of elevated levels of soluble -synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies
- (2009) K. E. Paleologou et al. BRAIN
- Amyloid- (1-42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease
- (2009) C. Mulder et al. CLINICAL CHEMISTRY
- Diagnosis and the premotor phase of Parkinson disease
- (2009) E. Tolosa et al. NEUROLOGY
- Incidental Lewy Body Disease and Preclinical Parkinson Disease
- (2008) Anthony DelleDonne et al. ARCHIVES OF NEUROLOGY
- Parkinson's disease: clinical features and diagnosis
- (2008) J Jankovic JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Red Blood Cells Are the Major Source of Alpha-Synuclein in Blood
- (2008) Robin Barbour et al. Neurodegenerative Diseases
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search